Key result
Congenic knock-in of normotensive C10QTL6 alleles into hypertensive rats lowered blood pressure by 30 mm Hg in vivo, highlighting a novel epistatic pathway involving Cuedc1 and aldosterone.
Why the study?
Little is known about the causal genes and modularized mechanisms governing regulatory connections of blood pressure quantitative trait loci in polygenic hypertension.
Mean Difference: 30
Does not yet inform clinical hypertension care; leaves open whether the Cuedc1-aldosterone epistatic pathway translates to human polygenic hypertension.
OBJECTIVES: Multiple quantitative trait loci (QTLs) for blood pressure (BP) have been detected in rat models of human polygenic hypertension. They influence BP physiologically via epistatic modules. Little is known about the causal genes and virtually nothing is known on modularized mechanisms governing their regulatory connections. METHODS AND RESULTS: Two genes responsible for two individual BP QTLs on rat Chromosome 18 have been identified that belong to the same epistatic module. Treacher Collins-Franceschetti syndrome 1 (Tcof1) gene is the only function candidate for C18QTL3. Haloacid dehalogenase like hydrolase domain containing 2 (Hdhd2), although a gene of previously unknown function, is C18QTL4, and encodes a newly identified phosphatase. The current work has provided the premier evidence that Hdhd2/C18QTL4 and Tcof1/C18QTL3 may be involved in polygenic hypertension. Hdhd2/C18QTL4 can regulate the function of Tcof1/C18QTL3 via de-phosphorylation, and, for the first time, furbishes a molecular mechanism in support of a genetically epistatic hierarchy between two BP QTLs, and thus authenticates the epistasis-common pathway paradigm. CONCLUSION: The pathway initiated by Hdhd2/C18QTL4 upstream of Tcof1/C18QTL3 reveals novel mechanistic insights into BP modulations. Their discovery might yield innovative therapeutic targets and diagnostic tools predicated on a novel BP cause and mechanism that is determined by a regulatory hierarchy. Optimizing the de-phosphorylation capability and its downstream target could be antihypertensive. The conceptual paradigm of an order and regulatory hierarchy may help unravel genetic and molecular relationships among certain human BP QTLs.
No takes yet. Share an insight, caveat, or question.
Chauvet et al. (2015) studied Polygenic hypertension. Congenic knock-in of normotensive C10QTL6/Cuedc1 alleles vs. Hypertensive DSS parental strain was evaluated on Blood pressure reduction in vivo (30 mm Hg reduction). Congenic knock-in of normotensive C10QTL6 alleles into hypertensive rats lowered blood pressure by 30 mm Hg in vivo, highlighting a novel epistatic pathway involving Cuedc1 and aldosterone.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: